50. Clinical benefit table: Zeel versus Hyalgan. Continuous outcome measures.

Study	Time	Treatment	Outcome (scale)	N of Pts	Baseline Mean	End of Study Mean	Absolute Benefit	Relative Difference
Nahler 1998	1‐4 wk	T: Zeel	Pain during movement (0‐100 mm VAS)	57	67	31	1 (W)	1.6% (W)
		C: Hyalgan		57	63	26
Nahler 1998	1‐4 wk	T: Zeel	Pain at night (0‐100 mm VAS)	57	33	9	4 (W)	11.4% (W)
		C: Hyalgan		57	35	7